Trial record 17 of 22 for: "Hemosiderosis" | "Iron Chelating Agents"
Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01511848|
Recruitment Status : Unknown
Verified February 2012 by Mohsen Saleh Elalfy, Ain Shams University.
Recruitment status was: Not yet recruiting
First Posted : January 19, 2012
Last Update Posted : February 6, 2012
Ain Shams University
Information provided by (Responsible Party):
Mohsen Saleh Elalfy, Ain Shams University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||February 2013|
|Estimated Study Completion Date :||February 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Elalfy MS, Adly AM, Wali Y, Tony S, Samir A, Elhenawy YI. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients. Eur J Haematol. 2015 Nov;95(5):411-20. doi: 10.1111/ejh.12507. Epub 2015 Mar 27.